SCHEMBL973052

SCHEMBL973052

Cn1cc(C(=O)Nc2ccccc2Br)c(C(F)(F)F)n1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.69
LMNA P02545 2/20 0.59
POLB P06746 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.50
STING1 Q86WV6 1/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 3/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45
MAPT P10636 1/20 0.44
IRAK4 Q9NWZ3 2/20 0.44
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
BACE1 P56817 1/20 0.42
BACE2 Q9Y5Z0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5357036 0.86 LMNA (0.60) ATMLMNAPOLBSTING1GAA
SCHEMBL12393702 0.86 LMNA (0.60) ATMLMNAPOLBSTING1GAA
SCHEMBL971566 0.85 POLB (0.66) ATMLMNAPOLBSMN1; SMN2STING1
SCHEMBL973582 0.84 LMNA (0.56) ATMLMNAPOLBSMN1; SMN2STING1
SCHEMBL3764560 0.84 LMNA (0.58) ATMLMNAPOLBSMN1; SMN2STING1
SCHEMBL21652207 0.84 LMNA (0.58) ATMLMNAPOLBSMN1; SMN2STING1
SCHEMBL9262427 0.83 LMNA (0.57) ATMLMNAPOLBSTING1GAA
SCHEMBL1085471 0.83 LMNA (0.57) ATMLMNAPOLBMAPTIRAK4
SCHEMBL122740 0.82 LMNA (0.56) ATMLMNAPOLBSMN1; SMN2STING1
SCHEMBL973104 0.82 LMNA (0.56) ATMLMNAPOLBSTING1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257530-B1 PROCESS FOR PREPARING SUBSTITUTED BIPHENYLANILIDES BAYER CROPSCIENCE AG (DE) 2011-10-12 EP disclosed
US-20110003999-A1 Process for Preparing Substituted Biphenylanilides BAYER CROPSCIENCE AG (DE) 2011-01-06 US disclosed
EP-2093216-A1 Process for preparing substituted biphenylanilides Bayer CropScience AG (DE) 2009-08-26 EP disclosed
US-7173055-B1 Pyrazolecarboxamide and pyrazolethioamide as fungicide SYNGENTA CROP PROTECTION, INC. (US) 2007-02-06 US disclosed
EP-1235811-B1 PYRAZOLECARBOXAMIDE AND PYRAZOLETHIOAMIDE AS FUNGICIDE SYNGENTA PARTICIPATIONS AG (CH) 2005-06-01 EP disclosed
EP-1235811-A1 PYRAZOLECARBOXAMIDE AND PYRAZOLETHIOAMIDE AS FUNGICIDE Syngenta Participations AG (CH) 2002-09-04 EP disclosed
WO-2001042223-A1 PYRAZOLECARBOXAMIDE AND PYRAZOLETHIOAMIDE AS FUNGICIDE SYNGENTA PARTICIPATIONS AG (CH) 2001-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003999-A1 Process for Preparing Substituted Biphenylanilides DDT, PAH, THOP1 ATM 3682/4885LMNA 3959/4885POLB 425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.